The growth of the biotech industry has become a recurring topic on Trending Health episodes, from headlines about Novo Nordisk products Ozempic and Wegovy, to the emergence of Moderna as a household name thanks to their mRNA COVID-19 vaccine. As more biotech companies emerge into the market, they bring with them a mix of challenges and opportunities. On this episode of Trending Health, Jen and Mindy are joined by special guest, Dean McAlister, EVP of Inizio Biotech, to discuss the latest headlines and stories from the biotech sector.
For more information about the work discussed in this episode & Inizio Biotech, check out “The Phase II Inflection Point: Investing to Maximize Asset Value”.
Podcast Tags: healthcare, healthcare news, life sciences, biotech
Panel – Dean McAlister, Jen Burke, Mindy McGrath
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Featured Vynamic Team Members
About Vynamic
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Want to learn more? Get in touch!
Related Podcasts:
Felice Walter
Rethinking Launch Planning: Investing Early for Launch Success
Life science organizations often encounter challenges with aligning strategy and execution during a product launch, leading to inefficiencies...
Read more
Felice Walter
Embedding launch excellence as a cultural mindset: Going beyond frameworks, playbooks, and functional checklists to empower teams to focus on what matters most
In today's competitive pharmaceutical environment, the success of product launches hinges on the ability to prioritize outcomes over rigid processes..
Read moreAccounts, Collaboration & Pragmatism: Reuters Pharma Customer Engagement Round-Up
Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s...
Listen now